SEC Form 4 · accession 0001291656-16-000015
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wilson Wai-Shun Cheung
Officer — CFO & Senior VP, Finance
Period of report
Aug 29, 2016
Accepted (ET)
Aug 29, 2016 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 29, 2016 | S | 1,872 | $10.3474 | D | 15,604 | D |
Table II — derivative securities
No Table II lines on this filing.